[Translation] An open, multicenter phase IV clinical trial of ceftriaxone sodium and sulbactam sodium for injection (2:1) in the treatment of patients with hematological bacterial infections

通过开放式、多中心临床研究，评价注射用头孢曲松钠舒巴坦钠（2:1）治疗血液科细菌感染患者的有效性和安全性。

[Translation]

An open, multicenter clinical study was conducted to evaluate the efficacy and safety of ceftriaxone sodium and sulbactam sodium for injection (2:1) in the treatment of patients with hematological bacterial infections.

Start Date10 May 2015

Sponsor / Collaborator

Xiangbei Welman Pharmaceutical Co., Ltd.

[+1]

CTR20132092 / RecruitingPhase 4

“注射用头孢曲松钠舒巴坦钠（2:1）”治疗儿科急性细菌性感染的多中心、开放、非对照Ⅳ期临床研究

[Translation] A multicenter, open, non-controlled phase IV clinical study of "Ceftriaxone Sodium and Sulbactam Sodium for Injection (2:1)" for the treatment of acute bacterial infections in children

评价“注射用头孢曲松钠舒巴坦钠（2:1）”在广泛使用条件下治疗小儿急性细菌性感染疾病的安全性和有效性，并为儿童给药方案的调整提供依据。

[Translation]

To evaluate the safety and efficacy of "cefotaxime sodium and sulbactam sodium for injection (2:1)" in the treatment of acute bacterial infections in children under widespread use conditions, and to provide a basis for adjusting the dosing regimen for children.

Start Date28 Apr 2015

Sponsor / Collaborator

Xiangbei Welman Pharmaceutical Co., Ltd.

[+1]

CTR20132537 / RecruitingPhase 3

头孢曲松钠舒巴坦钠治疗中、重度呼吸和泌尿系统急性细菌感染的随机、盲法、阳性药对照多中心Ⅲ期研究

[Translation] A randomized, blinded, active-controlled, multicenter phase III study of ceftriaxone sodium and sulbactam sodium in the treatment of moderate to severe acute bacterial infections of the respiratory and urinary systems

以注射用头孢哌酮钠舒巴坦钠(2:1)为对照，评价注射用头孢曲松钠舒巴坦钠(2:1)治疗中、重度呼吸和泌尿系统急性细菌感染的有效性和安全性。

[Translation]

To evaluate the efficacy and safety of ceftriaxone sodium:sulbactam sodium for injection (2:1) in the treatment of moderate to severe acute bacterial infections of the respiratory and urinary systems, using cefoperazone sodium:sulbactam sodium for injection (2:1) as a control.

Start Date22 Mar 2013

Sponsor / Collaborator

Beijing United Weihua Pharmaceutical Co., Ltd.

[+1]

100 Clinical Results associated with Ceftriaxone Sodium/Sulbactam sodium

100 Translational Medicine associated with Ceftriaxone Sodium/Sulbactam sodium

100 Patents (Medical) associated with Ceftriaxone Sodium/Sulbactam sodium

100 Deals associated with Ceftriaxone Sodium/Sulbactam sodium

External Link

KEGG	Wiki	ATC	Drug Bank
-	-	J01CG01	-

R&D Status

Approved

10 top approved records.

to view more data

Indication	Country/Location	Organization	Date
Bacterial Infections	CN	Xiangbei Welman Pharmaceutical Co., Ltd.	28 Jan 2011

Developing

10 top R&D records.

to view more data

Indication	Highest Phase	Country/Location	Organization	Date
Bacterial Infections	Phase 3	CN	Zhongshan Union Weihua Pharmaceutical Co. Ltd.	22 Mar 2013
Bacterial Infections	Phase 3	CN	Beijing United Weihua Pharmaceutical Co., Ltd.	22 Mar 2013

Clinical Result

Indication

Phase

Evaluation

View All Results

Translational Medicine

Boost your research with our translational medicine data.

view full example data

Deal

Boost your decision using our deal data.

view full example data

Core Patent

Boost your research with our Core Patent data.

view full example data

Clinical Trial

Identify the latest clinical trials across global registries.

view full example data

Approval

Accelerate your research with the latest regulatory approval information.

view full example data

Regulation

Understand key drug designations in just a few clicks with Synapse.

view full example data

Chat with Hiro

Get started for free today!

Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.

Start your data trial now!

Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.

Bio

Bio Sequences Search & Analysis

Chemical

Chemical Structures Search & Analysis